Category: Pharmacological Index

  • Adrisin®

    • TABLETS

    Composition: 1 tablet containing: Acidum arsenicosum D8, Acidum formicicum D8, Acidum sulfuricum D22, Arctium D8, Arnica montana D6, Graphites D10, Histaminum dihydrochloricum D8, Histaminum dihydrochloricum D12, Histaminum dihydrochloricum D22, Ledum palustre D8, Lycopodium clavatum D6, Pix pinaceae D10, Selenium D12, Stibium sulfuratum nigrum D10, Strychnos ignatii D6, Sulfur D12, Tellurium metallicum D10, Thuja occidentalis D6 15 mg each.

    Indications: For prevention and treatment of allergies.

    Contraindications: None known.

    Side effects: Persons with known hypersensitivity to plants of the daisy family (Asteraceae e. g. arnica) may react in isolated cases with hypersensitivity.

    Interactions with other medication: None known.

    Dosage: Standard dosage: Adults (and children 12 yrs. and older): 1 tablet to be dissolved in the mouth 3x daily.

    Package size: Packs containing 50 and 250 tablets. (71152)

    Pharmacological notes

    Acidum arsenicosum: respiratory allergy,¹,² suffocative catarrh,² allergy to dust,³ sneezing,⁴–¹¹ watery eyes,⁴,¹⁰,¹² itchy eyes,⁴,⁵,¹⁰–¹² burning eyes,¹⁶ and urticaria.⁷,¹⁷–²¹

    Acidum formicicum: asthmatic respiration.¹⁵,²²

    Acidum sulfuricum: allergic reactions in general,¹⁴,¹⁵ sneezing,³–⁵,¹¹,¹⁴,¹⁵ hay fever,¹⁴,¹⁵ itchy skin,⁴,⁵,⁷,¹⁴,¹⁷,²⁰,²³,²⁴ urticaria,²,⁷,¹⁴,¹⁵,¹⁷,²⁰,²¹,²⁵–²⁷ and coryza.⁴,⁵,¹¹,¹⁴,²³

    Arctium: asthma humida²⁸ and itchy eruptions of the skin.²,¹²,²⁸–³⁰

    Arnica montana: allergic reactions in general,¹⁴ urticaria,¹⁴,¹⁵ asthma,⁴,¹⁴,¹⁵,¹⁷,²⁰,²¹,³¹ and itchy vesicular eruptions.

    Graphites: hay fever¹⁴,¹⁵ and itchy skin eruptions.⁵,¹⁷,²⁰,²⁴,²⁹,³²–³⁵

    Histaminum dihydrochloricum: allergic reactions in general,²,¹⁴,²²,³⁶ hay fever,³⁶ itchy skin,¹⁵ and urticaria.²,¹⁴,¹⁵,³⁶

    Ledum palustre: allergic reactions in general,¹⁴ coryza,¹⁴,¹⁵,²¹ itchy skin eruptions,⁴,⁵,¹³–¹⁵,²¹,²⁵,²⁶ and asthmatic respiration.²,⁴–⁶,¹⁰,¹⁴,¹⁵,²³,²⁵,²⁹,³⁷

    Lycopodium clavatum: allergic reactions in general,³,¹⁴,¹⁵ watery eyes,⁴,²⁰,²¹,³⁸ asthmatic respiration,¹¹,¹⁸,²⁴,²⁶,²⁹–³¹,³⁷,³⁹,⁴⁰ itchy skin eruptions,⁴,⁵,⁸,¹³–¹⁵,¹⁷,²⁰,²¹,²⁴ and sneezing.⁴,⁵,¹³,¹⁴,²⁰,²⁴,²⁶,²⁹

    Pix pinaceae: itchy skin.²,⁷,⁸,¹⁴,¹⁹,²⁰,²⁶,²⁹

    Selenium: asthmatic respiration,¹⁴,¹⁵ itchy skin eruptions,²,⁸,¹⁴,¹⁵,²¹,²⁴,⁴¹ and coryza.⁴,⁵,¹⁸,²⁰,²³,²⁹,⁴²,⁴³

    Stibium sulfuratum nigrum: allergic reactions in general,¹⁴ asthmatic respiration,⁴,⁵,⁸,¹⁴,¹⁵,²³ itchy skin eruptions,⁸,¹⁴,¹⁵,²¹,²⁹ and coryza.²,⁴,⁵,¹⁴,¹⁵,²⁰,²³,²⁴,²⁶,²⁷,³¹

    Strychnos ignatii: asthmatic respiration,¹,¹⁴,¹⁵,³¹ itchy skin,²,⁴–⁶,⁸,¹⁴,¹⁵,²⁰,²⁶,²⁷,²⁹,⁴⁴ and coryza.²,⁴,⁵,¹⁴,¹⁵,²⁰,²¹,²³,²⁶,²⁹,³¹,⁴⁴

    Sulfur: allergic reactions in general,³,¹⁴,¹⁵,⁴⁰ asthmatic respiration,⁴,⁵,¹⁶–¹⁸,²⁴,²⁶,²⁹,³¹,³²,³⁹,⁴¹ itchy skin eruptions,⁴–⁶,¹³,¹⁷,²³,²⁹,³⁵,⁴⁵ and coryza.⁴,⁵,¹³,²⁶,²⁹,³¹,⁴¹,⁴⁶

    Tellurium metallicum: allergic condition,³⁶ itchy skin eruptions,⁴–⁶,¹⁴,¹⁵,²⁰,²¹,²⁵,³⁴,⁴¹,⁴⁴,⁴⁷ watery eyes,⁴,¹²,²¹,²⁷,⁴³,⁴⁸ and coryza.⁴–⁶,⁸,²⁰,²⁹,³⁶,⁴¹,⁴⁴,⁴⁸

    Thuja occidentalis: allergic reactions in general,¹⁴,¹⁵,¹⁸ asthmatic respiration,⁸,¹⁷,²⁰,²⁴,²⁶,²⁹,³²,³⁷,⁴³,⁴⁹ hay fever,³,¹⁴,¹⁵,¹⁸,⁴⁷ and itchy skin eruptions.²,⁴,¹²,¹⁴,¹⁵,¹⁹,²⁰,²⁶,²⁷

    Clinical notes

    Because of the individual constituents of Adrisin, the medication can be offered for common allergic symptoms:

    1. Respiratory system related: runny nose (coryza), sneezing, watery eyes, burning eye sensation, itchy eyes, suffocative catarrh, and hay fever.
    2. Skin related: skin irritations, pruritus, and allergy-caused urticaria.

    References

    1. Morrison R. Desktop Companion to Physical Pathology. 1st ed. Albany, CA: Hahnemann Clinic Publishing; 1998.
    2. Murphy R. The Homeopathic Remedy Guide: 1200 Homeopathic and Herbal Remedies. 1st ed. Blacksburg, VA: HANA Press; 2000.
    3. Vermeulen F. Prisma—The Arcana of Materia Medica Illuminated—Similars and Parallels Between Substance and Remedy. 2nd ed. Haarlem, the Netherlands: Emryss Publishers; 2002.
    4. Allen TF. The Encyclopedia of Pure Materia Medica: A Record of the Positive Effects of Drugs Upon the Healthy Human Organism. Vol 1-12. 1st ed. Ridgewood, NJ: Gregg Press Inc; 1964.
    5. Allen TF. Handbook of Materia Medica and Homeopathic Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1889.
    6. Allen TF. A Primer of Materia Medica for Practitioners of Homoeopathy. 1st ed. Philadelphia, PA: Boericke & Tafel; 1892.
    7. Blackwood AL. A Manual of Materia Medica, Therapeutics and Pharmacology (With Clinical Index). 2nd ed. New Delhi, India: World Homoeopathic Links; 1922.
    8. Boericke W. Pocket Manual of Homeopathic Materia Medica With Repertory, Comprising the Characteristic and Guiding Symptoms of All Remedies. 9th ed. Santa Rosa, CA: Boericke & Tafel; 1927.
    9. Dewey WA. Practical Homeopathic Therapeutics. 3rd ed. Philadelphia, PA: Boericke & Tafel; 1934.
    10. Hahnemann S. Materia Medica Pura. Vol 1-2. 1st ed. London, England: Homeopathic Book Publishers; 1880.
    11. Hahnemann S. The Chronic Diseases; Their Peculiar Nature and Their Homoeopathic Cure. Tafel LH, trans-ed. Vol 1-2. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1981.
    12. Hughes R, Dake JP. A Cyclopaedia of Drug Pathogenesy. Vol 1-4. 1st ed. New Delhi, India: World Homoeopathic Links; 1891.
    13. Dunham C. Lectures on Materia Medica. 3rd ed. London, England; New York, NY; Philadelphia, PA: Boericke & Tafel; 1934.
    14. Murphy R. Homeopathic Medical Repertory: A Modern Alphabetical Repertory. 1st ed. Pagosa Springs, CO: Hahnemann Academy of North America; 1993.
    15. Schroyens F. Synthesis: Repertorium Homeopathicum Syntheticum. 9th ed. London, England: Homeopathic Book Publishers; 2004.
    16. Farrington H. Homeopathy and Homeopathic Prescribing (Prepared for and Offered Only to Graduate Physicians). 1st ed. Philadelphia, PA: American Institute of Homeopathy; 1965.
    17. Burt WH. Physiological Materia Medica. 5th ed. Chicago, IL: Gross & Delbridge; 1896.
    18. Degroote F. Physical Examination and Observations in Homoeopathy. 1st ed. Gent, Belgium: Homoeoden Bookservice; 1992.
    19. Farrington EA. Clinical Materia Medica Being a Course of Lectures Delivered at the Hahnemann Medical College, of Philadelphia. 2nd ed. Philadelphia, PA: Hahnemann Publishing House; 1890.
    20. Hering C. The Guiding Symptoms of Our Materia Medica. Vol 1-10. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    21. Vermeulen F. Concordant Materia Medica. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 1997.
    22. Reckweg H-H. Homeopathia Antihomotoxica-Symptomen-und Modalitätenverzeichnis mit Arzneimittellehre. Vol 1-2. 6th ed. Baden-Baden, Germany: Aurelia Verlag; 1999.
    23. Buck H. The Outlines of Materia Medica and a Clinical Dictionary. 1st ed. New Delhi, India: Jain Publishers Ltd; 1865.
    24. Kent JT. Lectures on Homeopathic Materia Medica. 4th ed. London, England; New York, NY; Philadelphia, PA: Boericke & Tafel; 1946.
    25. Hughes R. Manual of Homeopathic Pharmacodynamics. 5th ed. London, England: Leath & Ross; 1886.
    26. Lilienthal S. Homoeopathic Therapeutics. 5th ed. Calcutta, India: Sett Dey & Co; 1925.
    27. Phatak SR. Materia Medica of Homoeopathic Medicines. 1st ed. London, England: Foxlee-Vaughan Publishers; 1988.
    28. Hale EM. Special Symptomatology of the New Remedies. New Delhi, India: Jain Publishers Ltd.
    29. Clarke JH. A Dictionary of Practical Materia Medica. Vol 1-3. 3rd ed. Bradford, England: Health Science Press; 1977.
    30. Farrington EA. Comparative Materia Medica. 3rd ed. New Delhi, India: Jain Publishers Ltd; 1983.
    31. Hoyne TS. Clinical Therapeutics. Vol 1-2. New Delhi, India: Jain Publishers Ltd; 1979.
    32. Cleveland CL. Salient Materia Medica and Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1888.
    33. Dunham C. Homoeopathy: The Science of Therapeutics (A Collection of Papers Elucidating and Illustrating the Principles of Homoeopathy). 1st ed. Philadelphia, PA: Boericke & Tafel; 1877.
    34. Gupta RL. Directory of Diseases and Cures in Homoeopathy: 1500 Authoritative References With Causes & Symptoms. Vol 1-2. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    35. Kulkarni S. Gynaecologic and Obstetric Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1994.
    36. Julian OA. Materia Medica of New Homeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1990.
    37. Mohanty N. Text-Book of Homoeopathic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1997.
    38. Sivaraman P. Expanded Works of Nash. 1st ed. New Delhi, India: Jain Publishers Ltd; 1995.
    39. Farrington EA. Lesser Writings With Therapeutic Hints. 1st ed. Calcutta, India: Salzer & Co; 1935.
    40. Herscu P. The Homeopathic Treatment of Children: Pediatric Constitutional Types. 1st ed. Berkeley, CA: North Atlantic Books; 1991.
    41. Leeser O. Textbook of Homoeopathic Materia Medica: Inorganic Medicinal Substances. 1st ed. New Delhi, India: Jain Publishers Ltd; 1980.
    42. Allen HC. Keynotes and Characteristics With Comparisons of Some of the Leading Remedies of the Materia Medica. 1st ed. Wellingborough, England: Thorsons Publishers Ltd; 1898.
    43. Boger CM. A Synoptic Key of the Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1931.
    44. Lippe A. Text Book of Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1865.
    45. Burt WH. Characteristic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1978.
    46. Gibson DM. Studies of Homeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1987.
    47. Vermeulen F. Synoptic Materia Medica. Vol 2. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 1998.
    48. Douglass ME. Pearls of Homeopathy. 1st ed. New Delhi, India: Jain Publishers Ltd; 1903.
    49. Choudhuri NM. A Study on Materia Medica and Repertory. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1929.

  • Restructa®

    • TABLETS
    Composition: 1 tablet containing: Colchicum autumnale D4, Bryonia D4, Formica rufa D4, Formica rufa D6, Formica rufa D10, Toxicodendron quercifolium D4, Cinchona pubescens D4, Ferrum phosphoricum D4, Acidum silicicum D6, Solidago virgaurea D2, Berberis vulgaris D2, Smilax D2 8.33 mg each.

    Indications: Rheumatic conditions and supportive treatment for gout.

    Contraindications: Pregnancy.

    Side effects: In very rare cases gastrointestinal complaints or skin reactions can occur – also some days after use. In rare cases, reactions of hypersensitivity such as skin allergy or fever may occur after exposure to drugs that contain quinine. In such cases, you must see a doctor. Note: A quinine or quinidine sensitisation may occur.

    Interactions with other medication: None known.

    Dosage: In acute conditions, 1 tablet to be taken orally with ample liquid every 30-60 minutes, not more than 6 times daily. In chronic disorders, 1 tablet to be taken orally with ample liquid 1-3 times daily. The medication should not be taken more than 1 week without medical advice.

    Package sizes: Packs containing 50 and 250 tablets. (42374)

    Pharmacological notes
    Colchicum autumnale: gout,¹–¹¹ rheumatism in general,¹,³,¹²–²⁰ and nephrolithiasis,²¹,²²
    Bryonia: rheumatic gouty diathesis,⁶,¹⁶,¹⁷,²²–²⁹ and red swollen joints.¹,⁴,⁶,⁸,¹⁸,²²,³⁰
    Formica rufa: gout,¹,²,⁶,¹³,¹⁷,¹⁹,²²,³⁰–³³ rheumatic pains in general,¹,²,⁵,⁶,¹²,¹³,¹⁹,²²,²⁷,³¹,³²,³⁴ and weakness of the lower extremities.¹,⁶,¹,⁹,³¹
    Toxicodendron quercifolium: gout,⁵–⁷,¹¹,¹⁷,²²,²⁴,²⁷,²⁹,³⁰,³⁵,³⁶ and rheumatic diathesis.⁵,⁷,⁸,¹⁰,¹⁵,²³,²⁵,²⁷,²⁹,³⁵,³⁷–³⁹
    Cinchona pubescens: Lyme disease.³¹
    Ferrum phosphoricum: gouty predisposition,²²,²⁶,³¹ rheumatism of the shoulder,¹,⁶,⁷,¹³,¹⁷,²²,²⁶,³⁰,³¹,³³ and rheumatism of the vertebral column.²⁷,³¹
    Acidum silicicum: gout¹,⁷,²²,²⁶,²⁷,³¹,³³,³⁵,⁴⁰,⁴¹ and rheumatism in general.⁶,⁷,¹⁰,¹²,¹³,¹⁷,²⁶,²⁷,³⁵,³⁹,⁴⁰,⁴²
    Solidago virgaurea: gout⁶,³⁰,³¹ and rheumatism.⁶,³⁰–³²
    Berberis vulgaris: gout¹,¹⁰,¹³,¹⁶–¹⁸,²³,²⁵–²⁷,²⁹ and rheumatism in general.¹,⁶,¹²,¹³,²³,²⁴,²⁶,²⁷,⁴³,⁴⁴
    Smilax: gout²,⁶,¹⁰,¹⁴,¹⁷,¹⁹,²²,²⁶,²⁹–³¹,³³ and rheumatism in general.¹,²,⁴,⁵,¹⁶,¹⁷,¹⁹,²⁴,²⁹,³¹,³³,³⁵

    Clinical notes
    Because of the individual constituents of Restructa, the medication can be offered for the following conditions:

    1. Gout and uric acid diathesis.
    2. To adjuvantly support the kidneys during gout and treat the formation of uric acid kidney stones.
    3. For rheumatism in general, rheumatism of the vertebral column, and rheumatism of the shoulder joints.

    Note: In acute conditions, in which redness, swelling, and warmth of the joints occur, and with non-resolving or unexplained conditions, medical advice must be sought; these symptoms may be the result of conditions that need further medical attention.

    References

    1. Boericke W. Pocket Manual of Homeopathic Materia Medica With Repertory, Comprising the Characteristic and Guiding Symptoms of All Remedies. 3rd ed. Santa Rosa, CA: Boericke & Tafel; 1927.
    2. Boger CM. A Synoptic Key of the Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1931.
    3. Burt WH. Characteristic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1978.
    4. Burt WH. Physiological Materia Medica. 3rd ed. Chicago, IL: Gross & Delbridge; 1896.
    5. Choudhuri NM. A Study on Materia Medica and Repertory. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1929.
    6. Clarke JH. A Dictionary of Practical Materia Medica. Vol 1-3. 3rd ed. Bradford, England: Health Science Press; 1977.
    7. Dudgeon WR. Lectures on Homoeopathic Therapeutics. Stuttgart, Germany: B. Jain Publishers Ltd; 1984.
    8. Douglas ME. Pearls of Homoeopathy. 1st ed. New Delhi, India: Jain Publishers Ltd; 1903.
    9. Dunham E. Lectures on Materia Medica. 3rd ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1934.
    10. Hahnemann S. Chronic Diseases, Their Peculiar Nature and Their Homoeopathic Cure. 2nd ed. New Delhi, India: B. Jain Publishers Ltd; 1992.
    11. Gibson DM. Studies of Homoeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1987.
    12. Allen TF. The Encyclopedia of Pure Materia Medica: A Record of the Positive Effects of Drugs Upon the Healthy Human Organism. Vol 1-12. 1st ed. New York, NY: Boericke & Tafel; 1874.
    13. Allen HC. Keynotes and Characteristics with Comparisons of Some of the Leading Remedies of the Materia Medica. 1st ed. Philadelphia, PA: Boericke & Tafel; 1898.
    14. Allen TF. A Primer of Materia Medica for Practitioners of Homoeopathy. 1st ed. Philadelphia, PA: Boericke & Tafel; 1892.
    15. Blackwood AL. A Manual of Materia Medica, Therapeutics and Pharmacology (With Clinical Index). 2nd ed. New Delhi, India: World Homoeopathic Links; 1992.
    16. Gupta RL. Directory of Diseases and Cures in Homoeopathy: 1500 Authoritative References With Causes & Symptoms. Vol 1-2. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    17. Hering C. The Guiding Symptoms of Our Materia Medica. Vol 1-10. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    18. Sivaraman P. Expanded Works of Nash. 1st ed. New Delhi, India: Jain Publishers Ltd; 1995.
    19. Phatak SR. Materia Medica of Homoeopathic Medicines. 1st ed. London, England: Foelx-Vaughan Publishers; 1988.
    20. Poirier J. Homoeopathic Treatment of the Diseases of Heart. Mukerjee RK, trans-ed. 1st ed. New Delhi, India: World Homoeopathic Links; 1982.
    21. Morrison R. Desktop Companion to Physical Pathology. 1st ed. Albany, CA: Hahnemann Clinic Publishing; 1998.
    22. Murphy R. Homoeopathic Medical Repertory: A Modern Alphabetical Repertory. 1st ed. Pagosa Springs, CO: Hahnemann Academy of North America; 1993.
    23. Allen HC. Keynotes and Characteristics With Comparisons of Some of the Leading Remedies of the Materia Medica. 1st ed. Wellingborough, England: Thorsons Publishers Ltd; 1898.
    24. Buck H. The Outlines of Materia Medica and a Clinical Dictionary. 1st ed. New Delhi, India: Jain Publishers Ltd; 1865.
    25. Farrington EA. A Clinical Materia Medica Being a Course of Lectures Delivered at the Hahnemann Medical College, of Philadelphia. 2nd ed. Philadelphia, PA: Hahnemann Publishing House; 1890.
    26. Kent JT. Lectures on Homoeopathic Materia Medica. 4th ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1905.
    27. Lilienthal S. Homoeopathic Therapeutics. 5th ed. Calcutta, India: S. S. T. & Co; 1925.
    28. Lippe A. Keynotes of Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1965.
    29. Murphy R. N+K Book of Homoeopathic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1997.
    30. Murphy R. The Homoeopathic Remedy Guide: 1200 Homoeopathic and Herbal Remedies. 1st ed. Blacksburg, VA: HANA Press; 2000.
    31. Schroyens F. Synthesis Repertorium Homoeopathicum Syntheticum. 9th ed. London, England: Homoeopathic Book Publishers; 2004.
    32. Vermeulen F. Synoptic Materia Medica. Vol 1. 6th ed. Haarlem, the Netherlands: Merlijn Publishers; 2000.
    33. Vermeulen F. Concordant Materia Medica. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 1997.
    34. Hale EM. Special Symptomatology of the New Remedies. New Delhi, India: B. Jain Publishers Ltd.
    35. Hoyne TS. Clinical Therapeutics. Vol 1-2. New Delhi, India: Jain Publishers Ltd; 1979.
    36. Hughes R. Manual of Homoeopathic Pharmacodynamics. 5th ed. London, England: Lewis & Ross; 1886.
    37. Allen HC. The Therapeutics of Intermittent Fever. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1884.
    38. Cleveland CL. Salient Materia Medica and Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1888.
    39. Farrington EA. Lesser Writings With Therapeutic Hints. 1st ed. Calcutta, India: Salzer & Co; 1935.
    40. Boericke W. Twelve Homoeopathic Materia Medica: Inorganic Medicinal Substances. 1st ed. New Delhi, India: Jain Publishers Ltd; 1980.
    41. Roberts HA. The Study of Remedies by Comparison. 1st ed. New Delhi, India: Jain Publishers Ltd; 1979.
    42. Hahnemann S. The Chronic Diseases: Their Peculiar Nature and Their Homoeopathic Cure. Tafel H, trans-ed. Vol 1-2. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1981.
    43. Hughes R, Dale JP. A Cyclopaedia of Drug Pathogenesy. Vol 1-4. 1st ed. New Delhi, India: World Homoeopathic Links; 1891.
    44. Lippe A. Keynotes and Red Line Symptoms of Materia Medica. New Delhi, India: Jain Publishers Ltd; 1998.

  • Neurexan®

    • DROPS · TABLETS

    Compositions:
    Drops: 100 g containing: Passiflora incarnata D2, Avena sativa D2, Coffea arabica D12, Zincum isovalerianicum D4 0.06 g each. Contains 36 vol.-% alcohol.
    Tablets: 1 tablet containing: Passiflora incarnata D2, Avena sativa D2, Coffea arabica D12, Zincum isovalerianicum D4 0.6 mg each.

    Indications: Nervous restlessness and sleep disturbances.
    Contraindications: Known allergy (hypersensitivity) to one or more of the ingredients.
    Side effects: Due to the homeopathic nature of Neurexan drops/tablets a temporary worsening in symptoms (initial aggravation) is possible but harmless. Tablets: Allergic (hypersensitivity) skin reactions may occur in very rare cases (i.e. affects less than 1 in 10,000 users).
    Interactions with other medication: None known.

    Dosage:
    Drops: Standard dosage: Adults and children 12 yrs. and older): 10 drops 3x daily. Acute or initial dosage: Adults (and children 12 yrs. and older): 10 drops every ½ to 1 hr., up to 12x daily, and then continue with standard dosage.
    Tablets: Standard dosage: Adults and children 12 yrs. and older): 1 tablet to be dissolved in the mouth 3x daily. Acute or initial dosage: Adults (and children 12 yrs. and older): 1 tablet every ½ to 1 hr., up to 12x daily, and then continue with standard dosage.

    Package sizes:
    Drops: Drop bottles containing 30 and 100 ml. (9880)
    Tablets: Packs containing 50 and 250 tablets. (9519)

    Pharmacological notes

    Passiflora incarnata: insomnia¹–⁹ and nervousness²,⁴–⁷,¹³

    Avena sativa: insomnia¹,⁵,⁸–¹⁰,¹¹ and nervousness¹,²,⁵,¹¹,¹³,¹⁴

    Coffea arabica: insomnia¹,⁴,⁶,¹⁰,¹²,¹⁵–²⁰ nervousness²,³,¹⁰,¹⁵,²¹–²⁸ irritability²,¹⁰,¹⁵,²⁵,²⁹ and restlessness²,⁶,⁸,¹⁵,²¹,³⁰–³²

    Zincum isovalerianicum: insomnia¹,⁶ and nervousness¹,⁶–⁸,¹²–¹⁵,²³,³³

    Clinical notes

    Because of the individual constituents of Neurexan, the medication can be offered for the following conditions:

    1. Nervousness or nervous restlessness. Empirically, in this condition, Neurexan is fast in onset and can be taken when necessary. This includes nervousness associated with overuse of coffee and other stimulants.
    2. Insomnia. Empirically, the best results are achieved after continuous use over a few weeks to restore the sleep pattern, although Neurexan will induce sleep when taken as necessary.
    3. Irritability and restlessness.

    References

    1. Blackwood A.L. A Manual of Materia Medica, Therapeutics and Pharmacology (With Clinical Index). 2nd ed. New Delhi, India: World Homeopathic Links; 1982.
    2. Boericke W. Pocket Manual of Homoeopathic Materia Medica With Repertory, Comprising the Characteristic and Guiding Symptoms of All Remedies. 6th ed. Santa Rosa, CA: Boericke & Tafel; 1927.
    3. Choudhuri NM. A Study on Materia Medica and Repertory. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1929.
    4. Lippe A. Keynotes and Red Line Symptoms of Materia Medica. New Delhi, India: Jain Publishers Ltd; 1998.
    5. Mohanty N. Text-Book of Homoeopathic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1997.
    6. Murphy R. Homoeopathic Medical Repertory: A Modern Alphabetical Repertory. 1st ed. Pagosa Springs, CO: Hahnemann Academy of North America; 1993.
    7. Murphy R. The Homoeopathic Remedy Guide: 1200 Homeopathic and Herbal Remedies. 1st ed. Blacksburg, VA: HANA Press; 2000.
    8. Phatak SR. Materia Medica of Homoeopathic Medicines. 1st ed. London, England: Fowler-Vaughan Publishers; 1988.
    9. Vermeulen F. Concordant Materia Medica. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 1997.
    10. Clarke JH. A Dictionary of Practical Materia Medica. Vol 1-3. 3rd ed. Bradford, England: Health Science Press; 1977.
    11. Gupta RL. Directory of Diseases and Cures in Homoeopathy: 1500 Authoritative References With Causes & Symptoms. Vol 1-2. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    12. Lilienthal S. Homoeopathic Therapeutics. 5th ed. Calcutta, India: Sett Dev & Co; 1925.
    13. Schroyens F. Synthesis: Repertorium Homeopathicum Syntheticum. 9th ed. London, England: Homeopathic Book Publishers; 2004.
    14. Dewey WA. Practical Homeopathic Therapeutics. 3rd ed. Philadelphia, PA: Boericke & Tafel; 1934.
    15. Burt WH. Physiological Materia Medica. 5th ed. Chicago, IL: Gross & Delbridge; 1896.
    16. Gibson DM. Studies of Homoeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1987.
    17. Morrison R. Desktop Companion to Physical Pathology. 1st ed. Albany, CA: Hahnemann Clinic Publishing; 1998.
    18. Boericke J. Homoeopathic Treatment of the Diseases of Heart. Mukerjee RK, trans-ed. New Delhi, India: World Homoeopathic Links; 1982.
    19. Rastogi DP. Homoeopathic Gems. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1997.
    20. Vermeulen F. Prisma–The Arcana of Materia Medica Illuminated–Similars and Parallels Between Substance and Remedy. 2nd ed. Haarlem, the Netherlands: Emryss Publishers; 2002.
    21. Allen TF. Handbook of Materia Medica and Homeopathic Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1889.
    22. Allen TF. A Primer of Materia Medica for Practitioners of Homoeopathy. 1st ed. Philadelphia, PA: Boericke & Tafel; 1892.
    23. Boericke GM. A Synoptic Key of the Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1931.
    24. Buck H. The Outlines of Materia Medica and a Clinical Dictionary. 1st ed. New Delhi, India: Jain Publishers Ltd; 1865.
    25. Burt WH. Characteristic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1978.
    26. Cleveland CL. Salient Materia Medica and Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1888.
    27. Farrington EA. Lesser Writings With Therapeutic Hints. 1st ed. Calcutta, India: Sizer & Co; 1935.
    28. Farrington EA. A Clinical Materia Medica Being a Course of Lectures Delivered at the Hahnemann Medical College, of Philadelphia. 2nd ed. Philadelphia, PA: Hahnemann Publishing House; 1890.
    29. Hering C. The Guiding Symptoms of Our Materia Medica. Vol 1-10. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    30. Allen HC. The Therapeutics of Intermittent Fever. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1884.
    31. Allen TF. The Encyclopedia of Pure Materia Medica: A Record of the Positive Effects of Drugs Upon the Healthy Human Organism. Vol 1-12. 1st ed. Ridgewood, NJ: Gregg Press; 1964.
    32. Royal G. Textbook of Homeopathic Materia Medica. 1st ed. Calcutta, India: Roy Publishing House; 1920.
    33. Hale EM. Special Symptomatology of the New Remedies. New Delhi, India: Jain Publishers Ltd.

  • Thyreoi­dea compositum

    DROPS · INJECTION SOLUTION

    Compositions:
    Drops: 100 g containing: Glandula thyreoidea suis D8, Thymus suis D10, Splen suis D10, Medulla ossis suis D10, Funiculus umbilicalis suis D10, Hepar suis D10, Galium aparine D4, Sedum acre D6, Sempervivum tectorum ssp. tectorum D6, Conium maculatum D4, Euspongia officinalis D8, Acidum sarcolacticum D4, Fucus vesiculosus D6, Calcium fluoratum D10, Colchicum autumnale D4, Viscum album D3, Cortisonum aceticum D28, Pulsatilla pratensis D8, Sulfur D10, Natrium diethyl­oxalaceticum D8, Acidum fumaricum D8, Acidum DL-malicum D8, Acidum alpha -ketoglutaricum D8, Adenosinum triphosphoricum D8 4 g each. Contains 35 vol.-% alcohol.
    Injection solution: 2.2 ml containing: Glandula thyreoidea suis D8, Thymus suis D10, Splen suis D10, Medulla ossis suis D10, Funiculus umbilicalis suis D10, Hepar suis D10, Galium aparine D4, Sedum acre D6, Sempervivum tectorum ssp. tectorum D6, Conium maculatum D4, Euspongia officinalis D8, Acidum sarcolacticum D3, Fucus vesiculosus D6, Calcium fluoratum D10, Colchicum autumnale D4, Viscum album D3, Cortisonum aceticum D28, Pulsatilla pratensis D8, Sulfur D10, Natrium diethyl­oxalaceticum D8, Acidum fumaricum D8, Acidum DL-malicum D8, Acidum alpha-ketoglutaricum D8, Adenosinum triphosphoricum D8 22 mg each.

    Indications:
    Stimulation of the defense system in connective tissue, thyroid and other glandular dysfunctions.

    Contraindications:
    Pregnancy and lactation. Viscum album containing products should not be used in persons with known allergies to mistletoe, in cases of chronic granulomatous and autoimmune diseases, and in cases of hyperthyroidism with an unbalanced metabolic condition. In acute inflammatory and highly feverish conditions, discontinue treatment until the inflammation and fever have disappeared.

    Side effects:
    A minor increase of body temperature, localized inflammatory reactions around the site where the subcutaneous injection was given as well as transient insignificant swellings of regional lymph nodes are harmless. Occasionally, veins may respond, presenting inflammatory irritative symptoms. A temporary interruption of the therapy will be necessary in that case. In the presence of an intolerance to mistletoe, there are rare cases where local or general allergic reactions or reactions similar to allergies, such as a generalized itchiness, urticaria, rash, swelling in the face (Quincke’s edema), shivering fits, dyspnea, sudden fall in blood pressure, shock, may occur; such reactions will require a discontinuation of the drug and an immediate medical treatment. In rare cases, an activation of inflammations may occur (eg, chronic sinusitis, apical granulomas).

    Interactions with other medication:
    None known.

    Dosage:
    Drops: Standard dosage: Adults (and children 12 yrs. and older): 10 drops 3x daily. Acute or initial dosage: Adults (and children 12 yrs. and older): 10 drops every ½ to 1 hr., up to 12x daily, and then continue with standard dosage.
    Injection solution: Standard dosage: Adults (and children 12 yrs. and older): 1 ampoule 1 to 3x weekly. Thyreoidea compositum injection solution may be administered by the s.c., i.d., i.m. or i.v. route.
    Acute or initial dosage: Adults (and children 12 yrs. and older): 1 ampoule daily, and then continue with standard dosage.

    Package sizes:
    Drops: Drop bottles containing 30 and 100 ml. (65812)
    Injection solution: Packs containing 10 and 100 ampoules of 2.2 ml each. (65908)

    Pharmacological notes
    Glandula thyreoidea suis: goiter, obesity-related cancerous conditions, and myxedema.¹˒²˒³
    Thymus suis: growth hormone disorders,¹˒³ cancerous conditions,¹˒² immune disorders, and lymphatic disorders.³
    Splen suis: anemia, leukemia, agranulocytosis,¹˒³ and immune deficiency.¹˒²
    Medulla ossis suis: anemic conditions, leukemia, agranulocytosis, coxitis, osteomalacia, chronic osteomyelitis, exostosis, arthritis deformans, and Morbus Sudeck.¹˒³
    Funiculus umbilicalis suis: chronic pathological features that involve the connective tissue.¹˒³
    Hepar suis: liver damage in general.¹˒³
    Galium aparine: cancer.⁴˒¹⁰
    Sedum acre: cancer.⁴˒⁹˒¹¹
    Sempervivum tectorum ssp. tectorum: cancer.⁴˒⁶˒¹²
    Conium maculatum: cancerous tendency,¹⁰˒¹³˒¹⁷ affected lymph glands,⁴˒⁵˒¹³˒¹⁸˒²⁷ and exhaustion.⁷˒⁸˒¹⁸˒²²˒²⁸˒³⁴
    Euspongia officinalis: lymphatic disorders,⁵˒⁸˒⁹˒¹¹˒¹⁶˒¹⁷˒²⁰˒³⁰˒³⁵˒³⁷ and hypertrophied thyroid glands.⁵˒⁷˒¹⁴˒¹⁸˒²¹˒²²˒²⁶˒²⁸˒³⁵˒³⁶˒³⁸˒⁴⁰
    Acidum sarcolacticum: painful cervical glands⁹˒¹⁰ and precancerous conditions.⁹˒¹¹˒⁴¹
    Fucus vesiculosus: thyroidal complaints and goiter.⁴˒⁸˒¹¹˒³⁹
    Calcium fluoratum: goiter,⁴˒⁷˒¹²˒²⁶˒³⁰˒⁴⁰ thyroiditis,⁴¹ and cancerous affections.⁸˒⁹˒²⁴
    Colchicum autumnale: goiter⁸ and gouty diathesis.⁴˒⁵˒⁹˒¹⁴˒¹⁸˒²⁰˒²¹˒²³˒²⁴˒²⁶˒²⁸˒³⁰˒³⁴˒³⁶˒³⁸˒⁴¹˒⁴²
    Viscum album: cancer.⁸˒⁹˒⁴¹
    Cortisonum aceticum: thyroidal complaints,⁹ goiter,¹¹˒⁴¹ damaged connective tissue,¹ and adrenal damage.¹˒³
    Pulsatilla pratensis: goiter,⁸ lymphatic disorders,⁸˒⁹˒²⁰˒²⁴˒³⁰˒³¹˒³⁵˒³⁶˒⁴³˒⁴⁵ and asthma.⁵˒¹⁵˒¹⁸˒²⁰˒²¹˒²⁸˒³⁰˒³¹˒³³˒³⁹˒⁴²˒⁴⁶˒⁴⁷
    Sulfur: goiter,⁸˒⁹˒²⁴˒³⁰ lymphatic disorders,⁵˒⁸˒⁹˒¹¹˒²¹˒³⁰˒³¹˒³⁶˒⁴³˒⁴⁸ scleroderma,⁸˒⁹˒⁴³ and asthma.⁵˒⁹˒¹⁰˒¹⁸˒²²˒²³˒³⁰˒³¹˒³⁴˒³⁶˒³⁸˒⁴²˒⁴⁷˒⁴⁹
    Natrium diethyl­oxalaceticum: asthma, cancerous conditions,¹ myopathia, and energy-deficit syndrome.³
    Acidum fumaricum: asthma, cancer, rheumatism,¹ and allergies of any kind.
    Acidum DL-malicum: asthma, precancerous conditions and neoplasma,¹ and rheumatic disorders.³
    Acidum alpha-ketoglutaricum: muscle and connective tissue disorders, soft tissue rheumatism,³ asthma, and precancerous conditions and neoplasma.¹
    Adenosinum triphosphoricum: cellular energy deficit¹˒³ and chronic fatigue syndrome.³

    Clinical notes
    Because of the individual constituents of Thyreoidea compositum, the medication can be offered for the following conditions:

    1. Adjunctive treatment in the dedifferentiation phases: precancerous conditions and frank neoplasms of various origins.
    2. Degenerative conditions: muscular dystrophy and arthrosis.
    3. Connective tissue dysfunction and disease: myxedema and scleroderma.
    4. Lymphatic disorders.
    5. Respiratory conditions: bronchial asthma.
    6. Gouty diathesis.

    Note:
    The unique formulation of Thyreoidea compositum makes it a medication with a broad application. It is especially useful for diseases classified on the right of the regulation/compensation division.

    References

    1. Reckeweg H-H. Homoeopathia Antihomotoxica: Symptomen-und Modalitätenverzeichnis mit Arzneimitteltherapie. Vol 1-2. 6th ed. Baden-Baden, Germany: Aurelia Verlag; 1999.
    2. Reinhart E. Suis-Organpräparate in der Homotoxikologie. 1st ed. Baden-Baden, Germany: Aurelia Verlag; 1994.
    3. Schmid F, Hamalick P. Antihomotoxische Medizin–Band II: Homöopathische Antihomotoxika. Vol 2. 1st ed. Baden-Baden, Germany: Aurelia Verlag; 1996.
    4. Boericke W. Pocket Manual of Homoeopathic Materia Medica With Repertory, Comprising the Characteristic and Guiding Symptoms of All Remedies. 9th ed. Santa Rosa, CA: Boericke & Tafel; 1927.
    5. Clarke JH. A Dictionary of Practical Materia Medica. Vol 1-3. 3rd ed. Bradford, England: Health Science Press; 1977.
    6. Hale EM. Special Symptomatology of the New Remedies. New Delhi, India: Jain Publishers Ltd; 1993.
    7. Lilienthal S. Homoeopathic Therapeutics. 5th ed. Calcutta, India: Sett Dey & Co.; 1925.
    8. Murphy R. Homeopathic Medical Repertory: A Modern Alphabetical Repertory. 1st ed. Pagosa Springs, CO: Hahnemann Academy of North America; 1993.
    9. Schroyens F. Synthesis: Repertorium Homeopathicum Syntheticum. 9th ed. London, England: Homeopathic Book Publishers; 2004.
    10. Vermeulen F. Concise Materia Medica. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 1997.
    11. Murphy R. The Homeopathic Remedy Guide: 1200 Homeopathic and Herbal Remedies. 1st ed. Blacksburg, VA: HANA Press; 2000.
    12. Blackwood AL. A Manual of Materia Medica, Therapeutics and Pharmacology (With Clinical Index). 2nd ed. New Delhi, India: World Homoeopathic Links; 1922.
    13. Allen KC. Keynotes and Characteristics With Comparisons of Some of the Leading Remedies of the Materia Medica. 12st ed. Wellingborough, England: Thorsons Publishers Ltd; 1988.
    14. Douglas MAS. Pearls of Homeopathy. 1st ed. New Delhi, India: Jain Publishers Ltd; 1903.
    15. Mohanty N. Text-Book of Homoeopathic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1997.
    16. Vermeulen F. Synoptic Materia Medica Vol. 1. 6th ed. Haarlem, the Netherlands: Merlijn Publishers; 2000.
    17. Vermeulen F. Prisma–The Arcana of Materia Medica Illuminated–Similars and Parallels Between Substance and Remedy. 2nd ed. Haarlem, the Netherlands: Emryss Publishers; 2002.
    18. Allen TF. Handbook of Materia Medica and Homeopathic Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1889.
    19. Allen TF. A Primer of Materia Medica for Practitioners of Homeopathy. 1st ed. Philadelphia, PA: Boericke & Tafel; 1892.
    20. Buck W. The Outlines of Materia Medica and a Clinical Dictionary. 1st ed. New Delhi, India: Jain Publishers Ltd; 1865.
    21. Burt WH. Characteristic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1978.
    22. Cleveland CL. Standard Materia Medica and Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1982.
    23. Dewey WA. Physical Examination and Observations in Homoeopathy. 1st ed. Gent, Belgium: Homoeodon Boekservice; 1992.
    24. Dewey WA. Practical Homeopathic Therapeutics. 3rd ed. Philadelphia, PA: Boericke & Tafel; 1934.
    25. Dunham C. Homeopathy: The Science of Therapeutics (A Collection of Papers Elucidating and Illustrating the Principles of Homeopathy). 1st ed. Philadelphia, PA: Boericke & Tafel; 1871.
    26. Gupta DR. Dictionary of Diseases and Cures in Homoeopathy: 1500 Authoritative References With Causes & Symptoms. Vol 1-2. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    27. Hahnemann S. The Chronic Diseases, Their Peculiar Nature and Their Homeopathic Cure. Tafel LH, trans-ed. Vol 1-2. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1981.
    28. Allen TF. The Encyclopedia of Pure Materia Medica: A Record of the Positive Effects of Drugs Upon the Healthy Human Organism. Vol 1-12. 1st ed. Ridgewood, NY: Gregg Press Inc.; 1964.
    29. Dunham C. Lectures on Materia Medica. 3rd ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1934.
    30. Hering C. The Guiding Symptoms of Our Materia Medica. Vol 1-10. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    31. Materia Medica–Synoptics. Vol 1-2. New Delhi, India: Jain Publishers Ltd; 1979.
    32. Kent JT. Lectures on Homoeopathic Materia Medica. 4th ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1946.
    33. Kulkarni S. Gynaecologic and Obstetric Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1994.
    34. Royal G. Textbook of Homoeopathic Materia Medica. 1st ed. Calcutta, India: Roy Publishing House; 1920.
    35. Burt WH. Physiological Materia Medica. 5th ed. Chicago, IL: Gross & Delbridge; 1896.
    36. Gibson DM. Studies of Homeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1987.
    37. Roberts HA. The Studies of Remedies by Comparison. 1st ed. New Delhi, India: Jain Publishers Ltd; 1979.
    38. Choudhuri NM. A Study on Materia Medica and Repertory. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1929.
    39. Morrison R. Desktop Companion to Physical Pathology. 1st ed. Albany, CA: Hahnemann Clinic Publishing; 1990.
    40. Phatak SR. Materia Medica of Homoeopathic Medicines. 1st ed. London, England: Kolve-Vaughan Publishers; 1980.
    41. Julian OA. Materia Medica of New Homoeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1990.
    42. Boericke GA. A Synoptic Key of the Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1931.
    43. Farrington H. Homoeopathy and Homoeopathic Philosophy (Prepared for and Offered Only to Graduate Physicians). 1st ed. Philadelphia, PA: American Homeopathic Pub Co.; 1922.
    44. Farrington EA. Comparative Materia Medica. 3rd ed. New Delhi, India: Jain Publishers Ltd; 1983.
    45. Hughes R. Manual of Homoeopathic Pharmacodynamics. 5th ed. London, England: Leath & Ross; 1886.
    46. Hahnemann S. Materia Medica Pura. Vol 1-2. 1st ed. London, England: Homeopathic Book Publishers; 1880.
    47. Herscu P. The Homeopathic Treatment of Children: Pediatric Constitutional Types. 1st ed. Berkeley, CA: North Atlantic Books; 1991.
    48. Hughes R, Dake JP. A Cyclopaedia of Drug Pathogenesy. Vol 1-4. 1st ed. New Delhi, India: World Homoeopathic Links; 1891.
    49. Farrington EA. Lesser Writings With Therapeutic Hints. 1st ed. Calcutta, India: Salzer & Co; 1935.

  • Zeel®

    Compositions:

    Tablets: 1 tablet containing: Cartilago suis D4 0.3 mg, Funiculus umbilicalis suis D4 0.3 mg, Embryo totalis suis D4 0.3 mg, Placenta totalis suis D4 0.3 mg, Rhus toxicodendron D2 0.54 mg, Arnica montana D1 0.6 mg, Solanum dulcamara D2 0.15 mg, Symphytum officinale D8 0.15 mg, Sanguinaria canadensis D3 0.45 mg, Sulfur D6 0.54 mg, Nadidum D6 0.03 mg, Coenzyme A D6 0.03 mg, Natrium diethyloxalaceticum D6 0.03 mg, Acidum DL-alpha liponicum D6 0.03 mg, Acidum silicicum D6 3 mg.

    Injection solution: 1 ampoule of 2.0 ml (≈ 2.0 g) contains: Cartilago suis D6 2 mg, Funiculus umbilicalis suis D6 2 mg, Embryo totalis suis D6 2 mg, Placenta totalis suis D6 2 mg, Solanum dulcamara D3 10 mg, Symphytum officinale D6 10 mg, Nadidum D8 2 mg, Coenzyme A D8 2 mg, Sanguinaria canadensis D4 3 mg, Natrium diethyloxalaceticum D8 2 mg, Acidum DL-alpha liponicum D8 2 mg, Rhus toxicodendron D2 10 mg, Arnica montana D4 200 mg, Sulfur D6 3.6 mg.

    Ointment: 100 g containing: Cartilago suis D2, Funiculus umbilicalis suis D2, Embryo suis D2, Placenta suis D2 0.001 g each; Rhus toxicodendron D2 0.270 g; Arnica montana D2 0.3 g; Solanum dulcamara D2 0.075 g; Symphytum officinale D8 0.75 g; Sanguinaria canadensis D2 0.225 g; Sulfur D6 0.27 g; Nadidum D6, Coenzyme A D6, Acidum DL-alpha liponicum D6, Natrium diethyloxalaceticum D6 0.01 g each; Acidum silicicum D6 1.0 g.

    Ointment base: Hydrophilic ointment (DAB 10) containing: emulsifying cetostearyl alcohol (type A), ethanol, purified water, liquid paraffin, white soft paraffin, preserved with 12.8 vol.-% alcohol.


    Indications:

    Arthrosis/osteoarthritis, in particular knee arthrosis, polyarthrosis, spondylarthrosis, rotator cuff syndrome. Rheumatic joint diseases.


    Contraindications:

    Known allergy (hypersensitivity) to one or more of the ingredients. Do not use during pregnancy and lactation.


    Side effects:

    Tablets, injection solution: Allergic (hypersensitivity) skin reactions may occur in very rare cases (i.e. affects less than 1 in 10,000 users).


    Interactions with other medication:

    None known.


    Dosage:

    Tablets – Standard dosage: Adults (and children 12 yrs. and older): 1 tablet to be dissolved in the mouth 3x daily. Acute or initial dosage: 1 tablet every ½ to 1 hr., up to 12x daily, then continue with standard dosage.

    Injection solution – Standard dosage: Adults and children 12 yrs. and older: 1 ampoule 1 to 3x weekly. May be administered by s.c., i.d., i.m., i.a. or i.v. route. Acute or initial dosage: 1 ampoule daily, then continue with standard dosage.

    Ointment – Standard dosage: Adults (and children 12 yrs. and older): Apply 2 to 4x daily. For external use only. Apply a thin layer over the affected area.


    Package sizes:

    • Tablets: Packs containing 50 and 250 tablets. (9757)
    • Injection solution: Packs containing 10 and 100 ampoules of 2.0 ml each. (8705)
    • Ointment: Tubes containing 50 and 100 g of ointment. (9588)


    Clinical notes:

    Zeel may protect against aspects of cartilage damage. The chondrocyte, which is the “control center” of the cartilage, regulates the oscillatory cycle of tissue destruction and regeneration, influenced by IL-6, IL-1, and TNF-α. These cytokines affect matrix metalloproteinases and synthesis of other substances. The regenerative cycle is supported by transforming growth factor-β and plant-based ingredients in Zeel.

    Zeel’s ingredients such as sulfur and cartilage-based tissue materials (e.g., Cartilago suis and Funiculus umbilicalis suis) may support connective tissue regeneration and modulate inflammation.

    References

    1. Clarke JH. A Dictionary of Practical Materia Medica. Vol 1–3. 3rd ed. Bradford, England: Health Science Press; 1977.
    2. Hering C. The Guiding Symptoms of Our Materia Medica. Vol 1–10. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    3. Murphy R. Homeopathic Medical Repertory: A Modern Alphabetical Repertory. 1st ed. Pagaso Springs, CO: Hahnemann Academy of North America; 1993.
    4. Schroyens F. Synthesis: Repertorium Homeopathicum Syntheticum. 9th ed. London, England: Homeopathic Book Publishers; 2004.
    5. Allen TF. The Encyclopedia of Pure Materia Medica: A Record of the Positive Effects of Drugs Upon the Healthy Human Organism. Vol 1–12. 1st ed. Ridgewood, NJ: Gregg Press Inc; 1964.
    6. Allen TF. Handbook of Materia Medica and Homeopathic Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1889.
    7. Boericke W. Pocket Manual of Homoeopathic Materia Medica With Repertory, Comprising the Characteristic and Guiding Symptoms of All Remedies. 9th ed. Santa Rosa, CA: Boericke & Tafel; 1927.
    8. Burt WH. Physiological Materia Medica. 5th ed. Chicago, IL: Gross & Delbridge; 1896.
    9. Gibson DM. Studies of Homeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1987.
    10. Hoyne TS. Clinical Therapeutics. Vol 1–2. New Delhi, India: Jain Publishers Ltd; 1979.
    11. Hughes R, Dake JP. A Cyclopaedia of Drug Pathogenesis. Vol 1–4. 1st ed. New Delhi, India: World Homoeopathic Links; 1891.
    12. Kent JT. Lectures on Homeopathic Materia Medica. 4th ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1946.
    13. Kulkarni S. Gynaecologic and Obstetric Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1994.
    14. Lilienthal S. Homeopathic Therapeutics. 5th ed. Calcutta, India: Sett Dey & Co; 1925.
    15. Morrison R. Desktop Companion to Physical Pathology. 1st ed. Albany, CA: Hahnemann Clinic Publishing; 1998.
    16. Allen HC. Keynotes and Characteristics With Comparisons of Some of the Leading Remedies of the Materia Medica. 1st ed. Wellingborough, England: Thorsons Publishers Ltd; 1987.
    17. Allen HC. The Therapeutics of Intermittent Fever. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1884.
    18. Blackwood AL. A Manual of Materia Medica, Therapeutics and Pharmacology (With Clinical Index). 2nd ed. New Delhi, India: World Homoeopathic Links; 1922.
    19. Choudhuri NM. A Study on Materia Medica and Repertory. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1988.
    20. Cleveland CL. Salient Materia Medica and Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1888.
    21. Degroote F. Physical Examination and Observations in Homoeopathy. 1st ed. Gent, Belgium: Homoeoden Bookservice; 1992.
    22. Dewey WA. Practical Homeopathic Therapeutics. 3rd ed. Philadelphia, PA: Boericke & Tafel; 1934.
    23. Douglass MF. Pearls of Homeopathy. 1st ed. New Delhi, India: Jain Publishers Ltd; 1903.
    24. Farrington EA. The Clinical Materia Medica Being a Course of Lectures Delivered at the Hahnemann Medical College, of Philadelphia. 2nd ed. Philadelphia, PA: Hahnemann Publishing House; 1900.
    25. Farrington EA. Lesser Writings With Therapeutic Hints. 1st ed. Calcutta, India: Salzer & Co; 1935.
    26. Mohanty N. Text-Book of Homoeopathic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1997.
    27. Royal G. Textbook of Homoeopathic Materia Medica. 1st ed. Calcutta, India: Roy Publishing House; 1920.
    28. Murphy R. The Homeopathic Remedy Guide: 1200 Homeopathic and Herbal Remedies. 1st ed. Blacksburg, VA: HANA Press; 2000.
    29. Vermeulen F. Concordant Materia Medica. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 1997.
    30. Phatak SR. Materia Medica of Homeopathic Medicines. 1st ed. London, England: Foulke-Vaughan Publishers; 1988.
    31. Dunham C. Lectures on Materia Medica. 3rd ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1934.
    32. Vermeulen F. Synoptic Materia Medica. Vol 1. 6th ed. Haarlem, the Netherlands: Merlijn Publishers; 2000.
    33. Hahnemann S. Materia Medica Pura. Vol 1–2. 1st ed. London, England: Homeopathic Book Publishers; 1800.
    34. Hahnemann S. The Chronic Diseases, Their Peculiar Nature and Their Homoeopathic Cure. Tafel LH, trans-ed. Vol 1–2. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1981.
    35. Wheeler CE. An Introduction to the Principles and Practice of Homoeopathy. 3rd ed. Saffron Walden, England: CW Daniel Co Ltd; 1948.
    36. Hughes R. Manual of Homoeopathic Pharmacodynamics. 5th ed. London, England: Leath & Ross; 1886.
    37. Boer CRM. A Synoptic Key of the Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1931.
    38. Buck H. The Outlines of Materia Medica and a Clinical Dictionary. 1st ed. New Delhi, India: Jain Publishers Ltd; 1865.
    39. Burt WH. Characteristic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1978.
    40. Farrington EA. Comparative Materia Medica. 3rd ed. New Delhi, India: Jain Publishers Ltd; 1983.
    41. Farrington EA. Clinical Materia Medica Being a Course of Lectures Delivered at the Hahnemann Medical College, of Philadelphia. 2nd ed. Philadelphia, PA: Hahnemann Publishing House; 1900.
    42. Lippe A. Keynotes and Red Line Symptoms of Materia Medica. New Delhi, India: Jain Publishers Ltd; 1998.
    43. Allen MF. Special Symptomatology of the New Remedies. New Delhi, India: Jain Publishers Ltd.
    44. Allen TF. A Primer of Materia Medica for Practitioners of Homoeopathy. 1st ed. Philadelphia, PA: Boericke & Tafel; 1892.
    45. Reinhart E. Suis-Orgnpräparate in der Homotoxikologie. 1st ed. Baden-Baden, Germany: Aurelia Verlag; 1994.
    46. Reckeweg H-H. Homoeopathia Antihomotoxica–Symptomen- und Modalitätenverzeichnis mit Arzneimittellehre. Vol 1–2. 6th ed. Baden-Baden, Germany: Aurelia Verlag; 1999.
    47. Schmidt F, Baumgärtel A. Antihomotoxische Medizin–Band II: Homöopathische Antihomotoxica. Vol 2. 1st ed. Baden-Baden, Germany: Aurelia Verlag; 1996.
    48. Gupta RL. Director of Diseases and Cures in Homoeopathy: 1500 Authoritative References With Causes & Symptoms. Vol 1–2. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    49. Rastogi DP. Homoeopathic Gems. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1993.
    50. Vermeulen F. Synoptic Materia Medica Illustrated–Similarities and Parallels Between Substance and Remedy. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 2002.
    51. Plotnik M, Siman R. Biomodulation of osteoarthritis. J Biomed Ther. 2008;2:47–4.

  • Detox Kit

    Indications:
    For relief of symptoms of illness caused by an unhealthy lifestyle (substance abuse or unbalanced diet) and/or exposure to environmental toxins (pollution, pesticides or allergens). Promotes detoxification.

    Ingredients:

    Nierentropfen Berberis Cosmoplex
    Oral drops: Berberis vulgaris Dil. D3 1.0 ml, Solidago virgaurea Dil. D3 1.0 ml, Lytta vesicatoria Dil. D5 0.8 ml

    Lymphomyosot®
    Oral drops: Each 100 ml contains: Geranium robertianum D4 (diarrhea; hemorrhages), Nasturtium aquaticum D4 (gastric disorders; stomatitis), Ferrum iodatum D12 (glandular enlargement; emaciation) 10 ml each; Juglans regia D3 (sharp occipital pain; facial acne), Myosotis arvensis D3 (chronic bronchitis; vomiting during cough), Scrophularia nodosa D3 (eczema of ear; scrofulous swelling), Teucrium scorodonia D3 (chronic rhinitis and bronchitis), Veronica officinalis D3 (chronic bronchitis; pruritus), Equisetum hyemale D4 (sharp burning pain in urethra while urinating), Fumaria officinalis D4 (hepatic disorders; eczema), Natrum sulphuricum D4 (asthma; symptoms worse in rainy weather), Pinus sylvestris D4 (stiffness; cramps in calves), Gentiana lutea D5 (ravenous hunger; nausea; stomach ache), Aranea diadema D6 (diarrhea; susceptibility to dampness and cold), Sarsaparilla D6 (colic with backache; cystitis), Calcarea phosphorica D12 (joint stiffness and pain, worse with changes of weather), Thyroidinum D12 5 ml each. Contains ethyl alcohol 25% by volume.

    Nux vomica-Homaccord®
    Oral drops: Each 100 ml contains: Colocynthis D3, D10, D30, D200 (agonizing pain in abdomen causing patient to bend over double), Lycopodium clavatum D3, D10, D30, D200, D1000 (abdomen is bloated immediately after a light meal) 0.3 ml each; Bryonia alba D3, D6, D10, D15, D30, D200, D1000 (pressure in stomach after eating; nausea and faintness when rising up), Nux vomica D3, D10, D15, D30, D200, D1000 (weight and pain in stomach worse after eating; stomach very sensitive to pressure) 0.2 ml each. Contains ethyl alcohol 25% by volume.

    Dosage:
    Adults and children above 11 years: Pour thirty drops of each bottle into a bottle of water and consume in one day. A physician should be consulted before using in children under 12 years of age.

    Dosage forms:
    Oral drops: Three dropper bottles containing 30ml each.

  • Zeel comp.

    Injection solution • Tablets Composition:

    Injection solution: 2,0 ml (= 2 g) cont.: Rhus toxicodendron D4 10 mg; Arnica montana D4 2 mg; Solanum dulcamara D4 1 mg; Sanguinaria canadensis D4 1 mg; Sulfur D10 3 mg.

    Tablets: 1 tablet cont.: Rhus toxicodendron D2 1 mg; Arnica montana D2 0,5 mg; Solanum dulcamara D2 0,3 mg; Sanguinaria canadensis D2 0,45 mg; Sulfur D6 0,75 mg.

    Indications:

    Arthrosis (in particular gonarthrosis); polyarthrosis, spondylarthrosis, scapulohumeral periarthritis.

    Contraindications:

    Hypersensitivity to botanicals of the Compositae family or the genus Rhus of the Anacardiaceae family.

    Side effects:

    None known.

    Interactions with other medication:

    None known.

    Dosage:

    Injection solution: In general twice weekly 1 ampoule i.m., s.c., i.d., i.v., intra-, periarticularly, or if necessary, paravertebrally. In the case of large joints, 2 ampoules on each occasion.

    Warning: In rare cases after intra-articular administration of Zeel comp. (injection solution), temporary painful joint irritation may occur, possibly with sterile effusions. Administration of anti-inflammatory medication is appropriate palliative treatment in such cases.

    Tablets: In general, 1 tablet to be dissolved under the tongue 3-5 times daily.

    Package sizes:

    Injection solution: Packs containing 10, 50 and 100 ampoules of 2,0 ml. Tablets: Packs containing 50 and 250 tablets.

    Pharmacological and clinical notes

    Rhus toxicodendron (poison oak)

    Rheumatism and neuralgia, worse in cold, wet weather; polyarthritis, diseases of the mucosa and connective tissues.

    Arnica montana (mountain arnica)

    To stimulate the healing of wounds, rheumatism, injuries arising from falls, blows or contusions; pains in the back and limbs.

    Solanum dulcamara (bittersweet)

    Remedy to counteract the effects of wet weather, sensation of having caught a chill, rheumatic disorders.

    Sanguinaria canadensis (blood-root)

    Neuralgic and rheumatoid pains of the joints and muscles. Sulfur (sulphur)

    Reagent in all chronic diseases; cellular activity is influenced catalytically.

  • Zeel® P

    Injection solution

    Zeel®

    Tablets

    Zeel® T

    Ointment Composition:

    Zeel P Injection solution: 2.2 ml cont.: Extractum (1:10) cartilaginissuis, Extractum (1:10) funiculiumbilicalis suis, Extractum (1:10) embryonissuis, Extractum (1:10) placentaesuis 22 ng each; Rhus toxicodendron Ø, Arnica montana Ø 0.22 mg each; Solanum dulcamara Ø, Symphytum officinale Ø 22 µg each; Sanguinaria canadensis  Ø 33 µg; Sulfur Ø (=D4) 39.6 µg; Nadidum, Coenzyme A, Acidum alpha-liponicum, Natrium diethyloxalaceticum 0.22 ng each.

    Zeel Tablets: 1 tablet cont.: Extractum (1:10) cartilaginis suis, Extractum (1:10) funiculiumbilicalis suis, Extractum (1:10) embryonissuis, Extractum (1:10) placentaesuis 0.3 µg each; Rhus toxicodendron Ø 0.108 mg, Extr. flor. Arnicae (spir. fld. 1:1) 0.06 mg; Solanum dulcamara Ø 3 µg; Symphytum officinale Ø 0.03 µg; Sanguinaria canadensis Ø 4.5 µg; Sulfur Ø 5.4 µg; Acidum silicicum colloidale 3 ng; Nadidum, Coenzyme A, Acidum alpha-liponicum, Natrium diethyloxalaceticum 0.03 ng each.

    Zeel T Ointment: 100 g cont.: Cartilago suis D2, Funiculus umbilicalis suis D2, Embryo suis D2, Placenta suis D2 0.001g each; Rhus toxicodendron D2 0.270 g; Arnica montana D2 0.300 g; Solanum dulcamara D2 0.075 g; Symphytum officinale D8 0.750

    g; Sanguinaria canadensis D2 0.225 g; Sulfur D6 0.270 g; Nadidum D6, Coenzymum  A D6, Acidum alpha-liponicum D6, Natrium diethyloxalaceticum D6 0.010 g each; Acidum silicicum D6 1.000 g.

    Ointment base: Hydrophilic ointment (DAB 10) cont.: Emulsifying cetylstearyl alcohol, ethanol, purified water, liquid paraffin, soft white paraffin, preserved with 12.9 vol.-% ethanol.

    Indications:

    Arthrosis (in particular gonarthrosis); polyarthrosis, spondylarthrosis, scapulohumeral periarthritis.

    Contraindications:

    Zeel P Injection solution: Hypersensitivity to botanicals of the Compositae family or the genus Rhus of the Anacardiaceae family.

    Zeel T Ointment: Hypersensitivity to arnica, the genus Rhus of the Anacardiaceae family and constituents of the ointment base.

    Zeel Tablets: Hypersensitivity to the genus Rhus of the Anacardiaceae family. Allergy to arnica.

    Side effects:

    Zeel T Ointment: In rare cases, allergic skin reactions may occur. Interactions with other medication:

    None known.

    Dosage:

    Zeel P Injection solution: In general twice weekly 1 ampoule i.m., s.c., i.d., i.v., intraarticularly, periarticularly, or if necessary, paravertebrally. In the case of large joints, 2 ampoules on each occasion.

    Warning: In rare cases after intra-articular administration of Zeel (P) (injection  solution), temporary painful joint irritation may occur, possibly with sterile effusions. Administration of anti-inflammatory medication is appropriate palliative treatment in such cases.

    Zeel Tablets: In general, 1 tablet to be dissolved under the tongue 3 times daily.

    Zeel T Ointment: Apply to the affected areas, rubbing in gently in the morning and evening, or if necessary more often, possibly applying an ointment dressing.

    Package sizes:

    Tablets: Packs containing 50 and 250 tablets.

    Injection solution: Packs containing 10, 50 and 100 ampoules of 2.2 ml. Ointment: Tubes containing 50 and 100 g of ointment.

    Pharmacological and clinical notes

    Cartilago suis (cartilage)

    Arthrosis deformans, coxitis, periarthritis humeroscapularis. Funiculus umbilicalis suis (Wharton’s jelly [umbilical cord]) Damage to connective tissues, circulatory disorders.

    Embryo suis (embryo)

    For revitalization in the cellular phases. Placenta suis (placenta)

    Circulatory disturbances, pernios. Rhus toxicodendron (poison oak)

    Rheumatism and neuralgia, worse in cold, wet weather; polyarthritis, diseases of the mucosa and connective tissues.

    Arnica montana (mountain arnica)

    To stimulate the healing of wounds, rheumatism, injuries arising from falls, blows or contusions; pains in the back and limbs.

    Solanum dulcamara (bittersweet)

    Remedy to counteract the effects of wet weather, sensation of having caught a chill, rheumatic disorders.

    Symphytum officinale (comfrey)

    Injuries to the tendons, ligaments and periosteum; acts on the joints in general, neuralgia of the knee.

    Sanguinaria canadensis (blood-root)

    Neuralgic and rheumatoid pains of the joints and muscles. Sulfur (sulphur)

    Reagent in all chronic diseases; cellular activity is influenced catalytically. Silicea (sillicic acid)

    Weakness and impairment of the connective tissues; weakness of the ligaments. Nadidum (nicotinamide adenine dinucleotide)

    Coenzyme, stimulation of the end oxidation in the respiratory chain. Coenzyme A (coenzyme A)

    Coenzyme for transacetylation. Acidum alpha-liponicum (thiotic acid)

    Coenzyme in the decomposition of pyruvic acid. Natrium diethyloxalaceticum (sodium oxalacetate)

    Active factor of the citric acid cycle and of redox systems; sensitivity to damp and wind. For the maintenance of normal articular functions, undisturbed co-ordination of the metabolism of the synovial membrane and synovial fluid on the one hand and of the arthrodial cartilage on the other, is indispensable. In the cartilage, according to the Embden-Meyerhof model, lactic acid or lactate is formed, which reaches the outer cellular layer of the joint capsule through the synovial fluid. There, by stimulation of the end oxidation through the citric acid cycle, the necessary energy is released. In arthrosis, there is a pathological alteration of the metabolism of the connective tissue  in the joint (cartilage, synovial membrane and also synovial fluid), characterized by increased degradation of the connective tissue structures. This results, therefore, in disproportion between catabolic and anabolic-metabolic processes. The task of effective therapy is to normalize the disturbed metabolism, as well as offering components for possible incorporation.

    The decisive energy-liberating reaction of the metabolism is the formation of hydrogen, which is then transferred, to a great extent, to nicotinamide adenine dinucleotide (nadidum); thus, for example, the whole of the hydrogen liberated in the course of the citric acid cycle is transferred to nadidum, the starting member of the respiratory chain. Precisely the oxidoreduction, catalysed by nadidum, between lactic acid and pyruvic acid, or the reverse, is of decisive importance in the metabolism of the joints.

    Thioctic acid is also a hydrogen-transferring co-factor which, above all, participates decisively in the oxidative decarboxylation (conversion of pyruvic acid to “activated acetic acid“).

    In the interaction with Coenzyme A, the formation of the “activated acetic acid” is made possible which, for its part, represents the

    “initiator” of the citric acid cycle, while oxalacetate can be described as the fuel, or also as the engine, of the citric acid cycle.

    The treatment of rheumatic diseases with sulphur has long been known. It is only through the biochemical research into mucopolysaccharide sulphates, however, that it was confirmed, i.e. could be established, that the organism can incorporate or convert the sulphur into chondroitin sulphates intrinsic to the body.

    The organ constituents provide important components of the connective tissue (cartilage, funiculus umbilicalis), while placenta pro-

    motes the circulation and the embryo has an additional stimulating action.

    The botanical constituents from Rhus toxicodendron, Solanum dulcamara, Sanguinaria canadensis, Symphytum and Arnica montana are applied for rheumatic diseases of the joints, etc., including when the disorders are worsened in wet weather.

    The medicaments blended into a pharmacologically active and non-toxic combination in Zeel, on the basis of many years’ medical experience and the most recent

    biochemical research form a highly valuable remedy for chronic diseases of the joints, as can be seen from the composition and from what has been confirmed by clinical  and practical tests.

    Based on the individual homoeopathic constituents of Zeel, therapeutic possibilities result for the treatment of arthrosis (in particular gonarthrosis), polyarthrosis, spondylarthrosis, periarthritis humeroscapularis.

    The dosage is adjusted according to the disease, the clinical picture and the stage of the illness: 1 tablet to be dissolved on the tongue 3-5 times daily. 1 ampoule or, for the big joints, 2 ampoules on each occasion, s.c., i.d., i.v., or periarticularly, possibly paravertebrally. The ointment should be applied or rubbed in morning and evening  and, if necessary, more often, at the affected areas, possibly using an ointment dressing.

    EXTENDED: Zeel® T Tablets

    Homeopathic medicinal product

    Product Type

    Registered homeopathic medicinal product; therefore, no therapeutic indication is given.
    If symptoms persist during use, consult a medical professional.

    Contraindications

    Do not use if there is a known hypersensitivity to any of the ingredients.
    In particular, persons with known hypersensitivity to composite plants (Asteraceae) and poison sumac must not use Zeel T due to the risk of an allergic reaction.

    Precautionary Measures for Use

    None.

    Consult your doctor before using any medicine during pregnancy or breastfeeding.
    There is insufficient documented experience regarding the use of this medicine in children.
    Therefore, it should only be used in children and adolescents under 18 years of age after consultation with a paediatrician.

    Interactions

    The effect of a homeopathic medicinal product can be adversely affected by generally harmful factors in lifestyle as well as by stimulants and recreational substances.

    Please inform your doctor or pharmacist if you are taking or have recently taken any other medicine, even if it is not prescription-only.

    Warnings

    This medicine contains lactose.
    Do not take this medicine without consulting your doctor if you know you have an intolerance to certain sugars.

    1 tablet = 0.025 BE

    Dosage and Method of Administration

    Unless otherwise prescribed:
    Let 1 tablet dissolve under the tongue 3–5 times a day.

    Duration of Use

    Even homeopathic medicines should not be taken over a longer period without medical advice.

    Side Effects

    Zeel T can cause side effects, although not everyone gets them.

    Due to the ingredient Rhus toxicodendron, gastrointestinal complaints or skin reactions may occur — even a few days after taking the medicine.

    In such cases, stop taking the medicine and consult a doctor.

    Note: When using a homeopathic medicine, existing symptoms may temporarily worsen (initial aggravation).
    In this case, stop taking the medicine and consult your doctor.

    Storage and Shelf Life

    Keep medicine out of reach of children.
    The expiry date is printed on the container and outer packaging.

    Do not use the medicine after the expiry date!

    No special storage conditions are required.

    After opening, shelf life is 12 months.

    Composition

    1 tablet (301.5 mg) contains the following active ingredients:

    SubstancePotencyQuantity
    Cartilago suisD4 (HAB, Regulation 42a)0.3 mg
    Funiculus umbilicalis suisD4 (HAB, Regulation 42a)0.3 mg
    Embryo suisD4 (HAB, Regulation 42a)0.3 mg
    Placenta suisD4 (HAB, Regulation 42a)0.3 mg
    Rhus toxicodendronD20.54 mg
    Arnica montana ØMother tincture0.6 mg
    Solanum dulcamaraD20.15 mg
    Symphytum officinaleD80.15 mg
    Sanguinaria canadensisD30.45 mg
    SulfurD60.54 mg
    NadidumD6 (HAB, Regulation 5a, Sol. D2 in distilled water)0.3 mg
    Coenzyme AD6 (HAB, Regulation 5a, Sol. D2 in distilled water)0.03 mg
    Natrium diethyloxalaceticumTrit. D6 (HAB, Regulation 6)0.03 mg
    Acidum silicicumTrit. D63 mg
    Acidum thioticumTrit. D6 (HAB, Regulation 6)0.03 mg

    Other ingredients:

    • Lactose monohydrate
    • Magnesium stearate

    Pack Size

    50 tablets

  • Ypsiloheel®

    Tablets Composition:

    tablet cont.: Asa foetida D4, Ignatia D4, Paris quadrifolia D4, Thuja occidentalis D6 30 mg each; Pulsatilla pratensis D4, Lachesis mutus D8, Moschus moschiferus D6, Glonoinum D6 45 mg each.

    Indications:

    Vegetative dystonia; globus hystericus.

    Dosage:

    In general, 1 tablet to be dissolved under the tongue 3 times daily.

    Package sizes:

    Packs containing 50 and 250 tablets.

    Pharmacological and clinical notes

    Asa foetida (asafetida)

    Globus hystericus, meteorism and flatulent colic, ostealgia. Ignatia (St. Ignatius’ bean)

    Vegetative dystonia, globus hystericus; long, deep, sighing respirations, inability to breathe normally, lability of mood, querulousness, migraine.

    Paris quadrifolia (herb Paris)

    Headache, globus hystericus, laryngitis, painless hoarseness. Thuja occidentalis (Arbor vitae)

    Constitutional remedy, especially in diseases with a tendency towards proliferative processes, difficulty in finding words, and other speech disorders, haemicrania, particularly in the left frontal eminence, malodorous perspiration.

    Pulsatilla pratensis (wind flower)

    Migrating disorders (worse before menses), dysmenorrhoea, remedy for affections of the mucous membranes, venous stasis, conjunctivitis; anxious, depressed female patients.

    Lachesis mutus (bushmaster)

    Sensation of globus, inattention to worsening condition, disorders worse in warmth from the sun, hot flushes with a sensation that clothing is too tight, garrulity, mistrust, the patient believes that he or she is being poisoned.

    Moschus moschiferus (musk, glandular secretion of the male musk deer) Laryngospasms, hysteria, nervous hyperactivity with tremors.

    Glonoinum (nitroglycerine)

    Palpitations extending to the neck, pulsations through the whole body, angina pectoris.

    Based on the individual homoeopathic constituents of Ypsiloheel, therapeutical possibilities result for the treatment of globus hystericus and other impregnation  phases localized at the neck. Ypsiloheel is indicated for all manifestations of vegetative dystonia, particularly in rapidly changing disorders of the most varied nature and for irrational symptoms, e.g. a feeling of foetal movements when there is no pregnancy. Ypsiloheel is also effective for migraine, ostealgia and coronary disorders of the circulation, as well as in duodenal ulcers and parapyloric syndrome with pyrosis (auxiliary remedies are Duodenoheel, Gastricumeel, possibly Anacardium-Homaccord, Nux vomica-Homaccord, Chelidonium-Homaccord, etc.).

    Also for chronic laryngitis and hoarseness, for struma parenchymatosa et colloides (Strumeel forte), for osteochondrosis of the cervical vertebrae with reflex symptoms of rachialgia (also globus hystericus is often caused by spondylolisthesis in the cervical region).

    In case vicarious headache occurs, in addition Gelsemium-Homaccord  and/or Spigelon as auxiliary remedy; for dizziness: Vertigoheel. For long-term treatment in addition Ignatia-Homaccord is well suited. Also for climacteric neurosis, especially when cardiac symptoms are also present (palpitations extending to the neck) as well  as mental alterations, Ypsiloheel (in addition to Klimakt-Heel, Nervoheel, Neuro-Injeel ampoules, Metro-Adnex-Injeel, Ovarium suis-Injeel, etc.) is indicated.

    The dosage is adjusted according to the disease, the symptoms and the state of the illness: 1 tablet dissolved on the tongue 3-4 times daily; for acute disorders, massive initial-dose therapy: 1 tablet every 15 minutes, alternating with auxiliary remedies.

  • Vomitusheel®

    Drops

    Vomitusheel® S

    Suppositories Composition:

    Vomitusheel Drops: 100 g cont.: Ipecacuanha D4, Aethusa cynapium D4, Nux vomica D4 10 g each; Apomorphinum hydrochloricum D6 15 g; Colchicum autumnale D6 25 g; Ignatia D6 30 g. Contains 35 vol.-% alcohol.

    Vomitusheel S Suppositories: 1 Suppository cont.: Ipecacuanha D2, Aethusa cynapium D2, Nux vomica D2 1.1 mg each; Apomorphinum hydrochloricum D4 1.65 mg; Colchicum autumnale D3 2.75 mg; Ignatia D4 3.3 mg.

    Indications:

    Vomiting and nausea of various origins.

    Dosage:

    Vomitusheel Drops: In general 10 drops 3 times daily; in acute conditions initially 10 drops every 15 minutes, over a period lasting up to two hours.

    Vomitusheel S Suppositories: Unless otherwise prescribed, in acute disorders, insert 1 suppository every hour into the anus; after alleviation of the trouble, only 1 suppository 2-3 times daily. For babies up to six months old, 1 suppository twice daily.

    Package sizes:

    Vomitusheel Drops: Drop bottles containing 30 and 100 ml.

    Vomitusheel S Suppositories: Packs containing 12, 60 and 120 suppositories of 2.0 g.

    Pharmacological and clinical notes

    Ipecacuanha (ipecacuanha)

    Nausea and vomiting, coughing with nausea. Aethusa cynapium (fool’s parsley)

    Cramp, pains, vomiting followed by great exhaustion; milk is not tolerated (brought up immediately by children).

    Nux vomica (vomit-nut)

    Remedy for affections of the stomach, intestine and liver; gastro-enteritis, meteorism, vomitus matutinus.

    Apomorphinum hydrochloricum (apomorphine hydrochloride) Nausea, vomiting, vomitus matutinus.

    Colchicum autumnale (meadow saffron)

    Gastro-enteritis, nausea and vomiting at the smell of food, tendency to collapse. lgnatia (St. Ignatius’ bean)

    Globus hystericus, gastro-intestinal spasms, meteorism, acid eructation.

    Based on the individual homoeopathic constituents of Vomitusheel, therapeutic possibilities result for the treatment of vomiting, nausea of various origins, etc., pylorospasms (in addition to Duodenoheel, Anacardium-Homaccord, Graphites- Homaccord, Erigotheel, etc.), vomiting after indigestible foods and sutoxins (Gastricumeel), gastro-enteritis with severe vomiting (Veratrum-Homaccord, Diarrheel S, etc.), travel sickness (in addition to Vertigoheel and possibly Cocculus-Homaccord). For vomiting from other origins, according to symptoms. Vomitusheel is a biological therapeutic agent without any

    undesirable side effects and it can be administered also to infants and children without any risk of harm.

    The dosage is adjusted according to the disease, the symptoms and the stage of the illness: 10 drops 3-4 times daily; in acute disorders, 10 drops every 10 minutes, possibly alternating with the other preparations indicated.